[EN] TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS TRICYCLIQUES INHIBITEURS DE PI3K ET PROCÉDÉS D'UTILISATION
申请人:HOFFMANN LA ROCHE
公开号:WO2012082997A1
公开(公告)日:2012-06-21
Tricyclic PI3k inhibitor compounds of Formula I with anti-cancer activity, anti- inflammatory activity, or immunoregulatory properties, and more specifically with PI3 kinase modulating or inhibitory activity are described. Methods are described for using the tricyclic PI3K inhibitor compounds of Formula I for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, organisms, or associated pathological conditions. Formula I compounds include stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof. The dashed lines indicate an optional double bond, and at least one dashed line is a double bond. The substituents are as described.
TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE
申请人:F.Hoffmann-La Roche AG
公开号:EP2651951A1
公开(公告)日:2013-10-23
Metal-Free-Visible Light C–H Alkylation of Heteroaromatics via Hypervalent Iodine-Promoted Decarboxylation
作者:Julien Genovino、Yajing Lian、Yuan Zhang、Taylor O. Hope、Antoine Juneau、Yohann Gagné、Gajendra Ingle、Mathieu Frenette
DOI:10.1021/acs.orglett.8b01085
日期:2018.6.1
A metal-free photoredox C–H alkylation of heteroaromatics from readily available carboxylicacids using an organic photocatalyst and hypervalent iodine reagents under blue LED light is reported. The developed methodology tolerates a broad range of functional groups and can be applied to the late-stage functionalization of drugs and drug-like molecules. The reaction mechanism was investigated with control